On August 24, 2025, MannKind Corp entered into a definitive merger agreement with scPharmaceuticals Inc. to acquire shares at $5.35 each, plus potential milestone payments totaling $1.00.
AI Assistant
MANNKIND CORP
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.